[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550668":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":19,"locations":25,"responsibleParty":163,"collaborators":10,"id":165,"slug":166,"hasResults":167,"nctId":168,"briefTitle":169,"officialTitle":170,"acronym":10,"eligibilityCriteria":171,"healthyVolunteers":167,"sex":172,"minAge":173,"maxAge":10,"enrollmentInfo":174,"targetDuration":10,"studyType":177,"phases":10,"briefSummary":178,"conditions":179,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":181,"lastUpdatePostDateStruct":182,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":190},{"fullName":5,"class":6},"Juventas Cell Therapy Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":9,"interventionNames":10},"Diagnosed relapsed or refractory B-cell acute lymphoblastic leukemia",null,[12,16],{"name":13,"affiliation":14,"role":15},"Jianxiang Wang, Dr.","Institute of Hematology & Blood Diseases Hospital, China","PRINCIPAL_INVESTIGATOR",{"name":17,"affiliation":18,"role":15},"Aibin Liang, Dr.","Tongji Hospital",[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Qinghan Wang, master","CONTACT","86-13439319658","352074861@qq.com",[26,45,55,69,83,97,111,125,137,151],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Peking University People's Hospital","RECRUITING","Beijing","Beijing Municipality","100000","China","CN",{"type":35,"coordinates":36},"Point",[37,38],116.39723,39.9075,{"lat":38,"lon":37},[41,43],{"name":42,"role":22,"phone":10,"phoneExt":10,"email":10},"Meng Lv, Dr.",{"name":44,"role":15,"phone":10,"phoneExt":10,"email":10},"Meng Lv",{"facility":46,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":47,"geoPoint":49,"contacts":50},"Peking University Third Hospital",{"type":35,"coordinates":48},[37,38],{"lat":38,"lon":37},[51,53],{"name":52,"role":22,"phone":10,"phoneExt":10,"email":10},"Hongmei Jing, Dr.",{"name":54,"role":15,"phone":10,"phoneExt":10,"email":10},"Hongmei Jing",{"facility":56,"status":28,"city":57,"state":58,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Zhujiang Hospital of Southern Medical University","Guangzhou","Guangdong",{"type":35,"coordinates":60},[61,62],113.25,23.11667,{"lat":62,"lon":61},[65,67],{"name":66,"role":22,"phone":10,"phoneExt":10,"email":10},"Yuhua Li, Dr.",{"name":68,"role":15,"phone":10,"phoneExt":10,"email":10},"Yuhua Li",{"facility":70,"status":28,"city":71,"state":72,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University","Zhengzhou","Henan",{"type":35,"coordinates":74},[75,76],113.64861,34.75778,{"lat":76,"lon":75},[79,81],{"name":80,"role":22,"phone":10,"phoneExt":10,"email":10},"Qingsong Yin, Dr.",{"name":82,"role":15,"phone":10,"phoneExt":10,"email":10},"Qingsong Yin",{"facility":84,"status":28,"city":85,"state":86,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","Wuhan","Hubei",{"type":35,"coordinates":88},[89,90],114.26667,30.58333,{"lat":90,"lon":89},[93,95],{"name":94,"role":22,"phone":10,"phoneExt":10,"email":10},"Heng Mei, Dr.",{"name":96,"role":15,"phone":10,"phoneExt":10,"email":10},"Heng Mei",{"facility":98,"status":28,"city":99,"state":100,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":101,"geoPoint":105,"contacts":106},"The Affiliated Hospital of Xuzhou Medical University","Xuzhou","Jiangsu",{"type":35,"coordinates":102},[103,104],117.28386,34.20442,{"lat":104,"lon":103},[107,109],{"name":108,"role":22,"phone":10,"phoneExt":10,"email":10},"Zhenyu Li, Dr.",{"name":110,"role":15,"phone":10,"phoneExt":10,"email":10},"Zhenyu Li",{"facility":112,"status":28,"city":113,"state":114,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":115,"geoPoint":119,"contacts":120},"Qilu Hospital of Shandong university","Jinan","Shandong",{"type":35,"coordinates":116},[117,118],116.99722,36.66833,{"lat":118,"lon":117},[121,123],{"name":122,"role":22,"phone":10,"phoneExt":10,"email":10},"Jun Peng, Dr.",{"name":124,"role":15,"phone":10,"phoneExt":10,"email":10},"Jun Peng",{"facility":126,"status":28,"city":127,"state":128,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"Tongji Hospital of Tongji University","Shanghai","Shanghai Municipality",{"type":35,"coordinates":130},[131,132],121.45806,31.22222,{"lat":132,"lon":131},[135,136],{"name":17,"role":22,"phone":10,"phoneExt":10,"email":10},{"name":17,"role":15,"phone":10,"phoneExt":10,"email":10},{"facility":138,"status":28,"city":139,"state":140,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":141,"geoPoint":145,"contacts":146},"West China School of Medicine\u002FWest China Hospital of Sichuan University","Chengdu","Sichuan",{"type":35,"coordinates":142},[143,144],104.06667,30.66667,{"lat":144,"lon":143},[147,149],{"name":148,"role":22,"phone":10,"phoneExt":10,"email":10},"Ting Niu, d",{"name":150,"role":15,"phone":10,"phoneExt":10,"email":10},"Ting Niu",{"facility":152,"status":28,"city":153,"state":154,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":155,"geoPoint":159,"contacts":160},"Institute of Hematology & Blood Diseases Hospital","Tianjin","Tianjin Municipality",{"type":35,"coordinates":156},[157,158],117.17667,39.14222,{"lat":158,"lon":157},[161,162],{"name":13,"role":22,"phone":10,"phoneExt":10,"email":10},{"name":13,"role":15,"phone":10,"phoneExt":10,"email":10},{"type":164,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100550668","inaticabtagene-autoleucel-injection-treatment-for-adult-relapsed-or-refractory-acute-lymphocytic-leukemia-100550668",false,"NCT06450067","Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia","To Observe and Evaluate the Efficacy and Safety of Inaticabtagene Autoleucel Injection in the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia in Adults in the Real World","Inclusion Criteria:\n\n1. Age ≥ 18 years;\n2. Diagnosed with relapsed or refractory B-cell acute lymphoblastic leukemia;\n3. Patients deemed eligible for receiving commercial Inaticabtagene Autoleucel injection treatment as determined by the investigator;\n4. Patients voluntarily participate in this study and sign an informed consent form. For patients lacking full legal capacity, informed consent must be obtained from their legal guardian\n\nExclusion Criteria:\n\nNone","ALL","18 Years",{"count":175,"type":176},200,"ESTIMATED","OBSERVATIONAL","This clinical trial is a non-interventional, observational, multicenter, post-marketing real-world study to evaluate the efficacy and safety of Inaticabtagene Autoleucel Injection in Chinese adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia.",[180],"B-cell Acute Lymphoblastic Leukemia","2024-09-18",{"date":183,"type":184},"2024-09-19","ACTUAL",{"date":186,"type":184},"2024-06-05",{"date":188,"type":176},"2029-06-05",{"name":5,"class":6},10]